Literature DB >> 10530842

Osteoid osteoma. Direct visual identification and intralesional excision of the nidus with minimal removal of bone.

M Campanacci1, P Ruggieri, A Gasbarrini, A Ferraro, L Campanacci.   

Abstract

We describe 100 consecutive patients with osteoid osteoma. Of the 97 who had operations, 89 were treated by intralesional excision and eight by wide resection. The three remaining patients were not operated on because the osteoid osteoma was almost painless, or was found in the pedicle of the 12th thoracic vertebra at the site of entrance of the artery of Adamkjewicz. The diagnosis was confirmed histologically in all specimens. No local recurrences were observed at a minimum follow-up of one year. All except one patient were mobilised two to four days after surgery. A precise preoperative diagnosis of the lesion is mandatory, based on clinical findings, standard radiographs, thin-section CT and a bone scan. We compared our operative technique with 247 cases in which the percutaneous technique of removal or coagulation of the nidus had been performed. The latter procedure has a less constant rate of primary cure (83% v 100%). Its principal indication appears to be for osteoid osteomas in the proximal femur and the pelvis.

Entities:  

Mesh:

Year:  1999        PMID: 10530842     DOI: 10.1302/0301-620x.81b5.9313

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  53 in total

Review 1.  Current trends in treatment of osteoid osteoma with an emphasis on radiofrequency ablation.

Authors:  Colin P Cantwell; John Obyrne; Stephen Eustace
Journal:  Eur Radiol       Date:  2003-12-09       Impact factor: 5.315

2.  CT-guided radiofrequency ablation of osteoid osteoma in the long bones of the lower extremity.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Daisuke Kakihara; Yasuhiro Ushijima; Yukihisa Takayama; Nobuhiro Fujita; Tsuyoshi Tajima; Kengo Yoshimitsu; Shuichi Matsuda; Yukihide Iwamoto; Hiroshi Honda
Journal:  World J Radiol       Date:  2012-06-28

3.  Radiofrequency ablation of osteoid osteoma in atypical locations: a case series.

Authors:  Shahram Akhlaghpoor; Alireza Aziz Ahari; Abbas Arjmand Shabestari; Mohammad Reza Alinaghizadeh
Journal:  Clin Orthop Relat Res       Date:  2010-02-20       Impact factor: 4.176

4.  Cost comparison of low-field (0.23 T) MRI-guided laser ablation and surgery in the treatment of osteoid osteoma.

Authors:  J Ronkainen; R Blanco Sequeiros; O Tervonen
Journal:  Eur Radiol       Date:  2006-04-25       Impact factor: 5.315

Review 5.  [Osteoidosteoma. From diagnosis to treatment].

Authors:  S D Sprengel; M-A Weber; B Lehner; C Rehnitz
Journal:  Radiologe       Date:  2015-06       Impact factor: 0.635

6.  Radiofrequency ablation in the treatment of osteoid osteoma: results and complications.

Authors:  Jeffrey Earhart; David Wellman; James Donaldson; Julie Chesterton; Erik King; Joseph A Janicki
Journal:  Pediatr Radiol       Date:  2013-02-14

7.  Osteoid osteoma of the triquetrum: a case of four-year delay in diagnosis.

Authors:  Samuel A Taylor; Samir K Trehan; Keith M Crivello; Robert Schneider; Scott W Wolfe
Journal:  HSS J       Date:  2014-03-28

8.  Radiofrequency thermoablation of primary non-spinal osteoid osteoma: optimization of the procedure.

Authors:  E Rimondi; Giuseppe Bianchi; M C Malaguti; R Ciminari; A Del Baldo; M Mercuri; U Albisinni
Journal:  Eur Radiol       Date:  2005-03-09       Impact factor: 5.315

9.  MR imaging-guided laser ablation of osteoid osteomas with use of optical instrument guidance at 0.23 T.

Authors:  Roberto Blanco Sequeiros; Pekka Hyvönen; Alberto Blanco Sequeiros; Lasse Jyrkinen; Risto Ojala; Rauli Klemola; Teuvo Vaara; Osmo Tervonen
Journal:  Eur Radiol       Date:  2003-05-07       Impact factor: 5.315

10.  Pitfalls in diagnostics of hip pain: osteoid osteoma and osteoblastoma.

Authors:  Georg von Chamier; Annette Holl-Wieden; Martin Stenzel; Peter Raab; Kassa Darge; Hermann J Girschick; Meinrad Beer
Journal:  Rheumatol Int       Date:  2009-05-15       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.